-
公开(公告)号:US20100119563A1
公开(公告)日:2010-05-13
申请号:US12532547
申请日:2008-03-21
申请人: Shinichi Miyagawa , Tatsuya Araki , Tsutomu Hamuro , Mika Okuda , Hiroshi Kaetsu
发明人: Shinichi Miyagawa , Tatsuya Araki , Tsutomu Hamuro , Mika Okuda , Hiroshi Kaetsu
CPC分类号: A61K38/363 , A61K31/198 , A61K38/38 , A61K38/45 , A61K38/4833 , A61K38/57 , A61L24/106 , A61L31/046 , C12Y203/02013 , C12Y304/21005 , A61K2300/00
摘要: A fibrinogen preparation is provided which has an improved solubility, may be prepared within a short time and may be used rapidly in clinical set-up. A solid fibrinogen preparation comprising as a main ingredient fibrinogen and further containing the following components: albumin; a nonionic surfactant; a basic amino acid or a salt thereof; and at least two amino acids or a salt thereof selected from an acidic amino acid or a salt thereof and a neutral amino acid or a salt thereof. The solid fibrinogen composition of the present invention may be held on a medical material to form a supporting material holding fibrinogen. Besides, the supporting material holding fibrinogen may be combined with a component comprising as a main ingredient thrombin to provide a fibrin adhesive.
摘要翻译: 提供具有改善的溶解性的纤维蛋白原制剂,可以在短时间内制备并且可以在临床装置中快速使用。 一种固体纤维蛋白原制剂,其包含作为主要成分的纤维蛋白原并进一步含有以下组分:白蛋白; 非离子表面活性剂; 碱性氨基酸或其盐; 和至少两个选自酸性氨基酸或其盐和中性氨基酸或其盐的氨基酸或其盐。 本发明的固体纤维蛋白原组合物可以保持在医疗材料上以形成保持纤维蛋白原的支撑材料。 此外,可以将含有纤维蛋白原的支持材料与包含作为主要成分凝血酶的组分组合以提供纤维蛋白粘合剂。
-
公开(公告)号:US09775884B2
公开(公告)日:2017-10-03
申请号:US12532547
申请日:2008-03-21
申请人: Shinichi Miyagawa , Tatsuya Araki , Tsutomu Hamuro , Mika Okuda , Hiroshi Kaetsu
发明人: Shinichi Miyagawa , Tatsuya Araki , Tsutomu Hamuro , Mika Okuda , Hiroshi Kaetsu
IPC分类号: A61K38/36 , A61K31/198 , A61K38/38 , A61K38/48 , A61L24/10 , A61L31/04 , A61K38/45 , A61K38/57
CPC分类号: A61K38/363 , A61K31/198 , A61K38/38 , A61K38/45 , A61K38/4833 , A61K38/57 , A61L24/106 , A61L31/046 , C12Y203/02013 , C12Y304/21005 , A61K2300/00
摘要: A fibrinogen preparation is provided which has an improved solubility, may be prepared within a short time and may be used rapidly in clinical set-up. A solid fibrinogen preparation comprising as a main ingredient fibrinogen and further containing the following components: albumin; a nonionic surfactant; a basic amino acid or a salt thereof; and at least two amino acids or a salt thereof selected from an acidic amino acid or a salt thereof and a neutral amino acid or a salt thereof. The solid fibrinogen composition of the present invention may be held on a medical material to form a supporting material holding fibrinogen. Besides, the supporting material holding fibrinogen may be combined with a component comprising as a main ingredient thrombin to provide a fibrin adhesive.
-